[Federal Register Volume 77, Number 111 (Friday, June 8, 2012)]
[Notices]
[Page 34072]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2012-13916]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Importer of Controlled Substances; Notice of Registration; Meda 
Pharmaceuticals, Inc.

    By Notice dated April 2, 2012, and published in the Federal 
Register on April 12, 2012, 77 FR 21998, Meda Pharmaceuticals, Inc., 
705 Eldorado Street, Decatur, Illinois 62523, made application by 
renewal to the Drug Enforcement Administration (DEA) to be registered 
as an importer of Nabilone (7379), a basic class of controlled 
substance listed in schedule II.
    The company plans to import the listed controlled substance for 
distribution to its customers.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and 952(a), and determined that the 
registration of Meda Pharmaceuticals Inc. to import the basic class of 
controlled substance is consistent with the public interest, and with 
United States obligations under international treaties, conventions, or 
protocols in effect on May 1, 1971. DEA has investigated Meda 
Pharmaceuticals Inc. to ensure that the company's registration is 
consistent with the public interest. The investigation has included 
inspection and testing of the company's physical security systems, 
verification of the company's compliance with state and local laws, and 
a review of the company's background and history. Therefore, pursuant 
to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34, 
the above named company is granted registration as an importer of the 
basic class of controlled substance listed.

    Dated: May 31, 2012.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 2012-13916 Filed 6-7-12; 8:45 am]
BILLING CODE 4410-09-P